(Q38213543)

31 August 2017

title

Lessons learned from the intrinsic subtypes of breast cancer in the quest for precision therapy (English)

1 reference

31 August 2017

1 reference

1 reference

3

T Sørlie

1 reference

31 August 2017

J H Norum

1

1 reference

31 August 2017

K Andersen

series ordinal

2

1 reference

31 August 2017

language of work or name

English

0 references

publication date

21 May 2014

1 reference

British Journal of Surgery

31 August 2017

published in

1 reference

31 August 2017

volume

101

1 reference

31 August 2017

issue

8

1 reference

31 August 2017

page(s)

925-938

1 reference

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

31 August 2017

cites work

1 reference

The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine

21 January 2018

1 reference

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

Molecular portraits of human breast tumours

21 January 2018

1 reference

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

Breast cancer molecular subtypes respond differently to preoperative chemotherapy

21 January 2018

1 reference

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

21 January 2018

1 reference

Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures

21 January 2018

1 reference

Gene expression in 16q is associated with survival and differs between Sørlie breast cancer subtypes

21 January 2018

1 reference

Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms

21 January 2018

1 reference

Molecular portraits of breast cancer: tumour subtypes as distinct disease entities

21 January 2018

1 reference

Comprehensive molecular portraits of human breast tumours

21 January 2018

1 reference

Genomic architecture characterizes tumor progression paths and fate in breast cancer patients

21 January 2018

1 reference

Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer

21 January 2018

1 reference

An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers

21 January 2018

1 reference

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer

21 January 2018

1 reference

Luminal-B breast cancer and novel therapeutic targets

21 January 2018

1 reference

Deconstructing the molecular portraits of breast cancer

21 January 2018

1 reference

Genomic instability in breast cancer: pathogenesis and clinical implications

21 January 2018

1 reference

Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer

21 January 2018

1 reference

BRCAness: a deeper insight into basal-like breast tumors

21 January 2018

1 reference

Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer.

21 January 2018

1 reference

Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype

21 January 2018

1 reference

Genomic analyses across six cancer types identify basal-like breast cancer as a unique molecular entity

21 January 2018

1 reference

Genomic pathway analysis reveals that EZH2 and HDAC4 represent mutually exclusive epigenetic pathways across human cancers

21 January 2018

1 reference

Supervised risk predictor of breast cancer based on intrinsic subtypes

21 January 2018

1 reference

Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors

21 January 2018

1 reference

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer

21 January 2018

1 reference

Identification of molecular apocrine breast tumours by microarray analysis.

21 January 2018

1 reference

Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation

21 January 2018

1 reference

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

21 January 2018

1 reference

Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics

21 January 2018

1 reference

miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors

21 January 2018

1 reference

MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype

21 January 2018

1 reference

Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns

21 January 2018

1 reference

Methylation profiling with a panel of cancer related genes: association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancer

21 January 2018

1 reference

Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signaling

21 January 2018

1 reference

Classification across gene expression microarray studies

21 January 2018

1 reference

Current composite-feature classification methods do not outperform simple single-genes classifiers in breast cancer prognosis.

21 January 2018

1 reference

Conservation of breast cancer molecular subtypes and transcriptional patterns of tumor progression across distinct ethnic populations

21 January 2018

1 reference

The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases

21 January 2018

1 reference

Assignment of tumor subtype by genomic testing and pathologic-based approximations: implications on patient's management and therapy selection.

21 January 2018

1 reference

Factors predicting late recurrence for estrogen receptor-positive breast cancer

21 January 2018

1 reference

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update

21 January 2018

1 reference

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies

21 January 2018

1 reference

Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study

21 January 2018

1 reference

High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses

21 January 2018

1 reference

Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial.

21 January 2018

1 reference

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

21 January 2018

1 reference

An international Ki67 reproducibility study

21 January 2018

1 reference

Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group

21 January 2018

1 reference

Comparison of PAM50 risk of recurrence score with oncotype DX and IHC4 for predicting risk of distant recurrence after endocrine therapy.

21 January 2018

1 reference

Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy al

21 January 2018

1 reference

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

21 January 2018

1 reference

Optimal tumor sampling for immunostaining of biomarkers in breast carcinoma

21 January 2018

1 reference

Biologic markers in ductal carcinoma in situ and concurrent infiltrating carcinoma. A comparison of eight contemporary grading systems

21 January 2018

1 reference

Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra-tumour genetic heterogeneity and clonal selection

21 January 2018

1 reference

Genome evolution during progression to breast cancer

21 January 2018

1 reference

Cancer as an evolutionary and ecological process

21 January 2018

1 reference

Genetic clonal diversity predicts progression to esophageal adenocarcinoma

21 January 2018

1 reference

The clonal evolution of tumor cell populations

21 January 2018

1 reference

Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic

21 January 2018

1 reference

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

21 January 2018

1 reference

Will cancer stem cells provide new therapeutic targets?

21 January 2018

1 reference

Breast cancer: origins and evolution

21 January 2018

1 reference

Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers

21 January 2018

1 reference

Phenotypic and functional characterisation of the luminal cell hierarchy of the mammary gland

21 January 2018

1 reference

Many tumors in one: a daunting therapeutic prospect

21 January 2018

1 reference

The perivascular niche regulates breast tumour dormancy.

21 January 2018

1 reference

Tumorigenic cells are common in mouse MPNSTs but their frequency depends upon tumor genotype and assay conditions

21 January 2018

1 reference

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

21 January 2018

1 reference

Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma.

21 January 2018

1 reference

The life history of 21 breast cancers

21 January 2018

1 reference

Clonal selection drives genetic divergence of metastatic medulloblastoma

21 January 2018

1 reference

Tumour heterogeneity and cancer cell plasticity

21 January 2018

1 reference

The epithelial-mesenchymal transition generates cells with properties of stem cells

21 January 2018

1 reference

Intra-tumour heterogeneity: a looking glass for cancer?

21 January 2018

1 reference

Cell plasticity and heterogeneity in cancer.

21 January 2018

1 reference

Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity

21 January 2018

1 reference

Rare somatic cells from human breast tissue exhibit extensive lineage plasticity

21 January 2018

1 reference

Metastatic behavior of breast cancer subtypes

21 January 2018

1 reference

Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study

21 January 2018

1 reference

Genomic copy number imbalances associated with bone and non-bone metastasis of early-stage breast cancer

21 January 2018

1 reference

Molecular profiling and characterization of luminal-like and basal-like in vivo breast cancer xenograft models

21 January 2018

1 reference

A new model of patient tumor-derived breast cancer xenografts for preclinical assays

21 January 2018

1 reference

Interplay of choline metabolites and genes in patient-derived breast cancer xenografts

21 January 2018

1 reference

Proteomic characterization of breast cancer xenografts identifies early and late bevacizumab-induced responses and predicts effective drug combinations

21 January 2018

1 reference

Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models

21 January 2018

1 reference

Xenografts faithfully recapitulate breast cancer-specific gene expression patterns of parent primary breast tumors

21 January 2018

1 reference

A renewable tissue resource of phenotypically stable, biologically and ethnically diverse, patient-derived human breast cancer xenograft models

21 January 2018

1 reference

Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes

21 January 2018

1 reference

Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures

21 January 2018

1 reference

Molecular profiling of patient-derived breast cancer xenografts

21 January 2018

1 reference

Breast tumor PDXs are genetically plastic and correspond to a subset of aggressive cancers prone to relapse

21 January 2018

1 reference

Genome remodelling in a basal-like breast cancer metastasis and xenograft

21 January 2018

1 reference

Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease

21 January 2018

1 reference

Developmental stage and time dictate the fate of Wnt/β-catenin-responsive stem cells in the mammary gland

21 January 2018

1 reference

In situ identification of bipotent stem cells in the mammary gland.

21 January 2018

1 reference

Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas

21 January 2018

1 reference

Research-Based PAM50 Subtype Predictor Identifies Higher Responses and Improved Survival Outcomes in HER2-Positive Breast Cancer in the NOAH Study

21 January 2018

1 reference

microRNA-Associated Progression Pathways and Potential Therapeutic Targets Identified by Integrated mRNA and microRNA Expression Profiling in Breast Cancer

21 January 2018

1 reference

Distinct stem cells contribute to mammary gland development and maintenance

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/BJS.9562

1 reference

31 August 2017

1 reference